vs
agilon health, inc.（AGL）与泰瑞达（TER）财务数据对比。点击上方公司名可切换其他公司
agilon health, inc.的季度营收约是泰瑞达的1.4倍（$1.6B vs $1.1B），泰瑞达净利率更高（23.7% vs -12.0%，领先35.8%），泰瑞达同比增速更快（43.9% vs 3.1%），泰瑞达自由现金流更多（$218.8M vs $-23.5M），过去两年泰瑞达的营收复合增速更高（34.4% vs -1.1%）
agilon health是一家美国医疗保健企业，主要与基层医疗服务提供者合作，为联邦医疗保险覆盖的老年群体提供价值导向型医疗解决方案，为医生提供行政支持、临床工具及风险管理框架，在提升诊疗效果的同时降低医疗成本，业务覆盖美国20余个州。
泰瑞达是总部位于美国马萨诸塞州北雷丁的自动测试设备（ATE）设计及制造企业，在全球半导体测试领域拥有深厚技术积累，服务的知名客户涵盖三星、高通、英特尔、亚德诺、德州仪器、IBM等行业头部企业。
AGL vs TER — 直观对比
营收规模更大
AGL
是对方的1.4倍
$1.1B
营收增速更快
TER
高出40.8%
3.1%
净利率更高
TER
高出35.8%
-12.0%
自由现金流更多
TER
多$242.3M
$-23.5M
两年增速更快
TER
近两年复合增速
-1.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.6B | $1.1B |
| 净利润 | $-188.9M | $257.2M |
| 毛利率 | — | 57.2% |
| 营业利润率 | -12.3% | 27.1% |
| 净利率 | -12.0% | 23.7% |
| 营收同比 | 3.1% | 43.9% |
| 净利润同比 | -78.5% | 75.9% |
| 每股收益（稀释后） | — | $1.62 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AGLTER
| Q4 25 | $1.6B | $1.1B | ||
| Q3 25 | $1.4B | $769.2M | ||
| Q2 25 | $1.4B | $651.8M | ||
| Q1 25 | $1.5B | $685.7M | ||
| Q4 24 | $1.5B | $752.9M | ||
| Q3 24 | $1.5B | $737.3M | ||
| Q2 24 | $1.5B | $729.9M | ||
| Q1 24 | $1.6B | $599.8M |
净利润AGLTER
| Q4 25 | $-188.9M | $257.2M | ||
| Q3 25 | $-110.2M | $119.6M | ||
| Q2 25 | $-104.4M | $78.4M | ||
| Q1 25 | $12.1M | $98.9M | ||
| Q4 24 | $-105.8M | $146.3M | ||
| Q3 24 | $-117.6M | $145.6M | ||
| Q2 24 | $-30.7M | $186.3M | ||
| Q1 24 | $-6.1M | $64.2M |
毛利率AGLTER
| Q4 25 | — | 57.2% | ||
| Q3 25 | — | 58.4% | ||
| Q2 25 | — | 57.2% | ||
| Q1 25 | — | 60.6% | ||
| Q4 24 | — | 59.4% | ||
| Q3 24 | — | 59.2% | ||
| Q2 24 | — | 58.3% | ||
| Q1 24 | — | 56.6% |
营业利润率AGLTER
| Q4 25 | -12.3% | 27.1% | ||
| Q3 25 | -9.1% | 18.9% | ||
| Q2 25 | -8.3% | 13.9% | ||
| Q1 25 | -1.4% | 17.6% | ||
| Q4 24 | -7.1% | 20.4% | ||
| Q3 24 | -9.2% | 20.6% | ||
| Q2 24 | -2.9% | 28.8% | ||
| Q1 24 | -0.4% | 13.0% |
净利率AGLTER
| Q4 25 | -12.0% | 23.7% | ||
| Q3 25 | -7.7% | 15.5% | ||
| Q2 25 | -7.5% | 12.0% | ||
| Q1 25 | 0.8% | 14.4% | ||
| Q4 24 | -6.9% | 19.4% | ||
| Q3 24 | -8.1% | 19.8% | ||
| Q2 24 | -2.1% | 25.5% | ||
| Q1 24 | -0.4% | 10.7% |
每股收益（稀释后）AGLTER
| Q4 25 | — | $1.62 | ||
| Q3 25 | — | $0.75 | ||
| Q2 25 | — | $0.49 | ||
| Q1 25 | — | $0.61 | ||
| Q4 24 | — | $0.89 | ||
| Q3 24 | — | $0.89 | ||
| Q2 24 | — | $1.14 | ||
| Q1 24 | — | $0.40 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $173.7M | $293.8M |
| 总债务越低越好 | $35.0M | — |
| 股东权益账面价值 | $126.7M | $2.8B |
| 总资产 | $1.3B | $4.2B |
| 负债/权益比越低杠杆越低 | 0.28× | — |
8季度趋势，按日历期对齐
现金及短期投资AGLTER
| Q4 25 | $173.7M | $293.8M | ||
| Q3 25 | $171.7M | $272.7M | ||
| Q2 25 | $171.4M | $339.3M | ||
| Q1 25 | $136.9M | $475.6M | ||
| Q4 24 | $188.2M | $553.4M | ||
| Q3 24 | $148.2M | $510.0M | ||
| Q2 24 | $109.5M | $421.9M | ||
| Q1 24 | $111.7M | $707.4M |
总债务AGLTER
| Q4 25 | $35.0M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益AGLTER
| Q4 25 | $126.7M | $2.8B | ||
| Q3 25 | $306.1M | $2.7B | ||
| Q2 25 | $408.9M | $2.8B | ||
| Q1 25 | $500.3M | $2.8B | ||
| Q4 24 | $471.0M | $2.8B | ||
| Q3 24 | $574.9M | $2.9B | ||
| Q2 24 | $676.6M | $2.7B | ||
| Q1 24 | $689.3M | $2.6B |
总资产AGLTER
| Q4 25 | $1.3B | $4.2B | ||
| Q3 25 | $1.6B | $4.0B | ||
| Q2 25 | $1.7B | $3.8B | ||
| Q1 25 | $1.9B | $3.7B | ||
| Q4 24 | $1.7B | $3.7B | ||
| Q3 24 | $2.1B | $3.8B | ||
| Q2 24 | $2.2B | $3.6B | ||
| Q1 24 | $2.3B | $3.4B |
负债/权益比AGLTER
| Q4 25 | 0.28× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-20.5M | $281.6M |
| 自由现金流经营现金流 - 资本支出 | $-23.5M | $218.8M |
| 自由现金流率自由现金流/营收 | -1.5% | 20.2% |
| 资本支出强度资本支出/营收 | 0.2% | 5.8% |
| 现金转化率经营现金流/净利润 | — | 1.09× |
| 过去12个月自由现金流最近4个季度 | $-119.0M | $450.4M |
8季度趋势，按日历期对齐
经营现金流AGLTER
| Q4 25 | $-20.5M | $281.6M | ||
| Q3 25 | $-18.2M | $49.0M | ||
| Q2 25 | $-35.1M | $182.1M | ||
| Q1 25 | $-32.0M | $161.6M | ||
| Q4 24 | $16.4M | $282.6M | ||
| Q3 24 | $-7.7M | $166.3M | ||
| Q2 24 | $-18.7M | $216.1M | ||
| Q1 24 | $-47.8M | $7.3M |
自由现金流AGLTER
| Q4 25 | $-23.5M | $218.8M | ||
| Q3 25 | $-21.3M | $2.4M | ||
| Q2 25 | $-38.3M | $131.7M | ||
| Q1 25 | $-35.8M | $97.6M | ||
| Q4 24 | $13.2M | $225.2M | ||
| Q3 24 | $-11.2M | $114.4M | ||
| Q2 24 | $-22.0M | $171.2M | ||
| Q1 24 | $-50.9M | $-36.7M |
自由现金流率AGLTER
| Q4 25 | -1.5% | 20.2% | ||
| Q3 25 | -1.5% | 0.3% | ||
| Q2 25 | -2.7% | 20.2% | ||
| Q1 25 | -2.3% | 14.2% | ||
| Q4 24 | 0.9% | 29.9% | ||
| Q3 24 | -0.8% | 15.5% | ||
| Q2 24 | -1.5% | 23.5% | ||
| Q1 24 | -3.2% | -6.1% |
资本支出强度AGLTER
| Q4 25 | 0.2% | 5.8% | ||
| Q3 25 | 0.2% | 6.1% | ||
| Q2 25 | 0.2% | 7.7% | ||
| Q1 25 | 0.3% | 9.3% | ||
| Q4 24 | 0.2% | 7.6% | ||
| Q3 24 | 0.2% | 7.0% | ||
| Q2 24 | 0.2% | 6.1% | ||
| Q1 24 | 0.2% | 7.3% |
现金转化率AGLTER
| Q4 25 | — | 1.09× | ||
| Q3 25 | — | 0.41× | ||
| Q2 25 | — | 2.32× | ||
| Q1 25 | -2.64× | 1.63× | ||
| Q4 24 | — | 1.93× | ||
| Q3 24 | — | 1.14× | ||
| Q2 24 | — | 1.16× | ||
| Q1 24 | — | 0.11× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AGL
| Medical Services | $1.6B | 100% |
| Other Operating | $2.5M | 0% |
TER
| Soc | $646.5M | 60% |
| Memory | $206.5M | 19% |
| Transferred At Point In Time | $90.0M | 8% |
| Universal Robots | $89.4M | 8% |
| IST | $30.5M | 3% |
| Transferred Over Time | $20.5M | 2% |
